HomeV5P • FRA
add
Vytrus Biotech SA
Previous close
€5.80
Day range
€5.85 - €6.15
Year range
€1.91 - €6.30
Market cap
51.21M EUR
Avg Volume
4.00
P/E ratio
22.75
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.51M | 65.77% |
Operating expense | 1.48M | 31.48% |
Net income | 720.96K | 182.33% |
Net profit margin | 28.68 | 70.31% |
Earnings per share | — | — |
EBITDA | 1.04M | 133.64% |
Effective tax rate | 10.16% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.29M | 48.08% |
Total assets | 13.17M | 23.72% |
Total liabilities | 4.27M | 11.16% |
Total equity | 8.90M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | 15.40% | — |
Return on capital | 19.65% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 720.96K | 182.33% |
Cash from operations | 874.07K | 176.21% |
Cash from investing | -455.00K | -49.11% |
Cash from financing | -40.58K | -107.44% |
Net change in cash | 378.48K | -32.04% |
Free cash flow | 270.35K | 1,342.48% |
About
Founded
2009
Website
Employees
41
